Table 2.
Analysis | Predictor | Regression coefficient |
Standard error |
t | p | Lower limit of 95% CI |
Upper limit of 95% CI |
---|---|---|---|---|---|---|---|
1 (MPQ-SC) | Constant | .758 | .097 | 7.796 | .000 | .566 | .950 |
Depression | .052 | .032 | 1.646 | .102 | −.011 | .115 | |
Anxiety | .075 | .028 | 2.712 | .008 | .020 | .129 | |
Positive symptoms | .056 | .045 | 1.253 | .212 | −.033 | .145 | |
Role functioning | −.002 | .011 | −.169 | .866 | −.024 | .020 | |
Social closeness | .006 | .012 | .503 | .616 | −.017 | .029 | |
Interaction | .001 | .004 | .199 | .843 | −.007 | .008 | |
2 (CAINS- MAP) |
Constant | .646 | .106 | 6.087 | .000 | .436 | .855 |
Depression | .075 | .035 | 2.168 | .032 | .007 | .143 | |
Anxiety | .070 | .030 | 2.342 | .021 | .011 | .129 | |
Positive symptoms | .131 | .048 | 2.726 | .007 | .036 | .226 | |
Role functioning | −.015 | .014 | −1.045 | .298 | −.042 | .013 | |
Negative symptoms- MAP |
−.008 | .007 | −1.143 | .255 | −.021 | .006 | |
Interaction | .004 | .002 | 2.417 | .017 | .001 | .007 | |
2 (CAINS- Express) |
Constant | .648 | .098 | 6.627 | .000 | .455 | .842 |
Depression | .078 | .033 | 2.340 | .021 | .012 | .143 | |
Anxiety | .068 | .028 | 2.421 | .017 | .012 | .123 | |
Positive symptoms | .105 | .044 | 2.395 | .018 | .018 | .191 | |
Role functioning | .001 | .012 | .070 | .945 | −.023 | .024 | |
Negative symptoms- Express |
.001 | .010 | .063 | .950 | −.018 | .019 | |
Interaction | −.001 | .003 | −.400 | .690 | −.007 | .005 |
Note: CI: Confidence interval. MPQ-SC: Multidimensional Personality Questionnaire-Social Closeness subscale. CAINS-MAP: Clinical Assessment Interview for Negative Symptoms-Motivation and Pleasure subscale. CAINS-Express: Clinical Assessment Interview for Negative Symptoms-Expression subscale. Suicide ideation measured by the Brief Psychiatric Rating Scale item 4; Depression measured by the Brief Psychiatric Rating Scale item 3; Anxiety measured by the Brief Psychiatric Rating Scale item 2; Positive symptoms measured by the Brief Psychiatric Rating Scale positive symptoms subscale; Role functioning measured by the Role Functioning Scale sum of items 3 and 4; Social closeness measured by the Multidimensional Personality Questionnaire-Social Closeness subscale; Negative symptoms-MAP measured by the Clinical Assessment Interview for Negative Symptoms-Motivation and Pleasure subscale; Negative symptoms-Express measured by the Clinical Assessment Interview for Negative Symptoms-Expression subscale. Interaction term is the multiplied effects of role functioning and social closeness (Analysis 1), motivation and pleasure-related negative symptoms (Analysis 2), or expression-related negative symptoms (Analysis 3).